21 May 2009
Complications after transplantation of kidney procured from the expanded criteria donors
P Domagała, A Kwiatkowski, M Wszoła, J Czerwiński, K Cybula, J Trzebicki, K Ostrowski, A ChmuraAnn Transplant 2009; 14(1): 50-51 :: ID: 880384
Abstract
Background: Organ shortage is the main barrier for kidney transplantation. In order to maximize organ utilization, expanded criteria donor's organs have been used increasingly. Expanded criteria donor is defined as a donor older than 60 years or a donor older than 50 years with at least two of the following: hypertension, stroke as a cause of death or serum creatinine greater than 1.5 mg/dl. Aim: The aim of this study was to assess the number of complications after transplantation of kidneys harvested from the expanded criteria deceased donors in comparison to organs retrieved from standard criteria deceased donors.
Material/Methods: One hundred and seventy two patients received cadaveric renal transplants between January 1st,2006 and August 31st,2008. Data on donors and recipients was collected. Patient and graft survival as well as immediate, delayed and slow graft function were analysed. Kidney function was assessed by serum creatinine concentration and creatinine clearance according to Cockroft-Gault formula at seven days, 1, 3, 6, 12 and 24 months post transplantation. The follow-up was completed on November 30[sup]th[/sup], 2008. All patients were followed-up for three to thirty five months.
Results: Average 1-year graft survival was 86.9% for the whole group and mean creatinine concentration was 1.58 ml/dl. One case of primary nonfunction was observed (0.6%). More than 25% of transplanted kidneys were harvested from ECD. There were no significant differences in postoperative complications between recipients of standard criteria donor's (SCD) and ECD organs (Table).
Conclusions: Recipients of expanded criteria donor's kidneys experience
a comparable rate of complications to recipients of standard criteria donor's kidneys.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






